1. P573 Real-world effectiveness and safety of vedolizumab and anti-TNF in biologic-naive ulcerative colitis patients: Results from the EVOLVE study. (25th January 2019) Authors: Yarur, A; Mantzaris, G; Silverberg, M; Walshe, M; Zezos, P; Stein, D; Bassel, M; Lissoos, T; Lopez, C; Natsios, A; Radulescu, G; Patel, H; Demuth, D; Bressler, B Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S400 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P546 Vedolizumab outcomes in real-world bio-naive ulcerative colitis and Crohn's disease patients (EVOLVE) in Canada: Interim results. (16th January 2018) Authors: Bressler, B; Greenup, A -J; Bassel, M; Stein, D; Soni, M; Radulescu, G; Neish, C; Khalid, J M; Demuth, D Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S382 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P419 Clinical effectiveness and safety of first-line biologic vedolizumab as a monotherapy or combination therapy in ulcerative colitis and Crohn's disease patients: results from the EVOLVE study. (15th January 2020) Authors: Bressler, B; Yarur, A; Kopylov, U; Bassel, M; Brett, N; Colby, C; Lopez, C; Saha, S; Kifnidi, C; Agboton, C; Adsul, S; Demuth, D; Luo, M; Wang, S; Mantzaris, G J Journal: Journal of Crohn's and colitis Issue: Volume 14(2020)Supplement 1 Page Start: S381 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Eddy currents in fine polycrystalline metal particle. (August 2019) Authors: Bassel, M; Yushkanov, A A Journal: Journal of physics Issue: Volume 1309(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P636 Real-world clinical effectiveness and safety of vedolizumab and ustekinumab in biologic-naïve patients with Crohn's disease: Results from the EVOLVE Expansion study. (30th January 2023) Authors: Ferrante, M; Christensen, B; Bressler, B; Brett, N; Bassel, M; Kamble, P; Adsul, S; Gianchetti, L; Scharl, M Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i768 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P772 Association of histological remission with long-term clinical outcomes in patients with ulcerative colitis: a multi-national retrospective study with centralized histological assessment. (30th January 2023) Authors: Jairath, V; Armuzzi, A; Pai, R K; Sun, D; Li, Y; Bassel, M; Brett, N R; Bojic, D Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i900 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗